Under the deal, LLR will provide access to new therapies currently being researched by its scientists, as well as offer financial support for Cancer Research UK to develop
MuGard is designed to manage oral mucositis by forming a protective hydrogel coating over the oral mucosa to shield the membranes of the mouth and tongue. PlasmaTech Biopharmaceuticals
AKB-6548 is designed to stabilize hypoxia inducible factor (HIF), a transcription factor that regulates the expression of genes involved with red blood cell (RBC) production in response to
Keytruda is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. The breakthrough status for Keytruda is to treat these patients
As part of the acquisition, MPI will acquire the Jasper Clinic, a 50-bed clinical trial unit that offers a wide range of early-stage study services, including pharmacokinetic and
EPP is characterized by an extreme risk of severe burns of the skin resulting in intolerable pain, swelling, scarring and a state of distress. The company said that
The latest acquisition will be combined with CSL’s existing vaccines and pharmaceutical subsidiary, bioCSL. The transaction requires regulatory approvals and is expected to be completed in the second
Targin is a fixed combination of opioid agonist oxycodone and opioid antagonist naloxone in prolonged-release oral tablets. The drug, which is currently licensed for the treatment of RLS
The drug secured CHMP positive opinion for treatment of mCRPC patients who are asymptomatic or mildly symptomatic after failure of androgen-deprivation therapy in whom chemotherapy is not yet
AHA is a very rare and potentially life-threatening acute bleeding disorder that typically affects older adults and occurs in both males and females. Obizur, which contains a recombinant
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.